Lexaria Bioscience Corp.
NASDAQ:LEXX
Overview | Financials
Company Name | Lexaria Bioscience Corp. |
Symbol | LEXX |
Currency | USD |
Price | 2.83 |
Market Cap | 44,742,866 |
Dividend Yield | 0% |
52-week-range | 0.987 - 6.85 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Christopher A. Bunka |
Website | https://www.lexariabioscience.com |
An error occurred while fetching data.
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD